A chronic total occlusion (CTO) occurs in an artery when all blood flow is blocked for more than three months, which causes the blood to flow through smaller vessels, as well as angina. If a guidewire cannot be passed through a lesion, it will not be possible to deploy a stent, a percutaneous transluminal coronary angioplasty (PTCA) balloon or any plaque-debulking device.
The primary uses of balloon-inflation devices are to inflate dilation balloons for stent placement as well as to inject contrast agents for use in diagnostic procedures. Balloon-inflation devices usually consist of a syringe, and sometimes a pressure gauge and a tube to connect the inflation device to the balloon catheter. Balloon-inflation devices are commonly designed to be inflated and deflated with one hand, allowing them to be operated very easily by just one person.
Accurate product and industry research is a time consuming and costly affair, but a necessary part of any successful market player. Our MedFolio line of products can ease research burdens by compiling the latest product information across an entire market segment. We have aggregated hundreds of products by category and company, as well as comprehensive lists of press releases, regulatory announcements and future product developments. MedFolio is ideal for companies with small or limited research teams as well as those who need to supplement their research departments with new data. A MedFolio includes the following products (*Not all products are available in every MedFolio, for more information, consult the MedFolio product page of a specific report):
Product Portfolio (Current Products on Market)
Product Pipelines (Future Products)
Cardiac surgery and heart valve procedures accounts for a large array of procedures. Generally, cardiac surgery is done through open heart surgery where a surgeon opens the chest and heart. For heart valves, the surgeon could replace or repair the damaged heart valve. Another common cardiac surgery procedure would be coronary artery bypass grafting where a harvested vein is grafted onto the heart to bypass blocked arteries. This procedure can be done on-pump, where a cardioplegic solution is sued to stop the heart and the patient is put on a heart-lung machine, or off-pump, also known as beating heart surgery.
Transmyocardial revascularization (TMR) is a surgically performed laser-based heart treatment procedure in which transmural channels are made in the heart muscle. Many scientific experts believe that these procedures encourage new vessel formation, also known as angiogenesis. TMR therapy is approved for patients suffering from chronic or severe angina. The American Heart Association (AHA) estimates that approximately 9.8 million Americans experience angina symptoms.
Ventricular assist devices (VADs) are used for aiding a failing heart by supplementing the pumping function of the heart. VADs are often used in patients with advanced heart failure (HF). HF is a chronic disease that occurs when degeneration of the heart muscle reduces the pump power of the heart, which causes the heart to become too weak to pump blood at a level sufficient to meet the bodys demands. The condition may be caused by arterial and valve diseases or cardiomyopathy, which is disease of the heart muscle itself. Other conditions such as high blood pressure or diabetes may also lead to HF.
The human heart contains four valves: the mitral valve, tricuspid valve, aortic valve and pulmonary valve. The mitral valve is most prone to regurgitation, which is a condition where blood is funneled back into the left atrium of the heart. Mitral regurgitation (MR) can either be caused by a congenital defect or myxomatous degeneration of the valve. Individuals with MR can suffer from atrial fibrillation, heart muscle dysfunction and even sudden death caused by cardiac arrest. In the U.S., there are just over
4 million people that may have MR, with only a minority actually diagnosed. The standard of care for MR is open surgery and/or the use of annuloplasty rings.
Artificial heart devices can be temporary or permanent mechanical devices that are designed to replace the function of a biological heart. The term artificial heart should not be used for describing ventricular assist devices (VADs). VADs are pumps that assist the heart but are not designed to replace it. Instead, they are used in collaboration with a patients heart. An artificial heart is also distinct from a cardiopulmonary bypass machine (CPB), which is an external device used for providing the functions of both the heart and lungs. CPBs are only used for a few hours at a time, most commonly during heart surgery. Artificial hearts were originally intended to be a permanent replacement for the biological human heart.
Tissue valves, which are also known as bioprosthetic valves, are harvested from either human donors or animal tissue. Human tissue valves can either be obtained from donor cadavers in allograft procedures, or from ones own body in an autograft procedure. Allograft valves may be acquired from deceased family members or anonymous donors. Autograft valves may be obtained through a Ross procedure, whereby part of the pulmonary valve is grafted and harvested into the aortic position. Whether autograft or allograft, human donor valves involve complicated extraction and insertion procedures. Human tissue valves are in limited supply and typically do not function drastically better than xenograft valves.
A patent foramen ovale (PFO) is a defect in the septum between the two atrial chambers of the heart. Specifically, the defect is an incomplete closure of the atrial septum that results in the creation of a flap or a valve-like opening in the atrial septal wall. A PFO is distinct from a secundum atrial septal defect (ASD). A PFO is present in everyone before birth but seals shut in most people. In adults, PFO occurs when the atrial septum, which is responsible for recycling blood during womb development, does not properly occlude after birth. The condition is very common, affecting over 20% of the population. Individuals with PFO are more likely to suffer a stroke and there is evidence that migraines can be a symptom of the condition. Those who have a PFO as well as migraines often experience sensations during their migraine that include shimmering spots, blurred vision and blind spots. There are many cases where PFO patients do not need to undergo surgery and drug treatment and continual monitoring are the only measures that are necessary. However, open surgical and interventional procedures are common in patients who run the risk of having a sudden cardiac arrest.
Remote hemodynamic monitoring devices are implanted into the patient to monitor the blood pressure in the pulmonary artery. The device takes measurements from inside the body and transmits the data to a secure website for clinicians to review. The clinicians are then able to preemptively able to detect heart failure and treat them before symptoms arise.
OPCAB procedures are much harder to perform because the beating heart adds difficulty in performing a bypass on the posterior and lateral walls of the heart. Surgeons have found many ways to stabilize the heart to bypass the necessary arteries. Most commonly, stabilizer and positioner devices are used in surgeries to aid physicians in stabilizing and positioning the heart and arteries.
The majority of coronary artery bypass graft (CABG) procedures are performed with the heart stopped. This type of procedure is termed on-pump coronary artery bypass (ONCAB) because the procedure requires the usage of a cardiopulmonary bypass (CPB). CPB is a technique that temporarily takes over the function of the heart and lungs during surgery, maintaining the circulation of blood and the oxygen content of the body. The CPB pump itself is often referred to as a heart-lung machine. In addition to the heart-lung machine, a complete extracorporeal bypass system is composed of various single-use products, called disposables for the purposes of this report. As disposables come into direct contact with the patients blood, they cannot be reused for safety reasons and must be disposed of and replaced following each procedure.
The left atrial appendage (LAA) is a small pouch in the wall of the left atrium. It is unknown what function the LAA performs.
In patients with normal heart rhythm, the heart contracts with each heartbeat. As the heart contracts, blood is pushed from the left atrial appendage into the left atrium and from the left atrium into the left ventricle.
Mechanical heart valves are prosthetic devices designed to replicate the function of the natural valves of the human heart. Mechanical valves are designed to outlast the patient and some have been stress-tested to last several hundred years. Although mechanical valves are long-lasting and generally only require one surgery for installation, they contribute to an increased risk of blood clot formation. As a result, mechanical valve recipients often take anti-coagulant (blood thinning) drugs such as warfarin for the rest of their lives, which makes the patient more prone to bleeding. Given their durability, mechanical valves are primarily indicated for younger patients and for mitral valve replacement due to its high-pressure gradient. The primary advantage of mechanical over tissue valves is that once a mechanical valve is implanted, they never wear down and rarely need to be replaced. Mechanical valves are made from either pyrolytic carbon or titanium that has been coated with pyrolytic carbon. Pyrolytic carbon is similar to graphite and is used for many biomedical applications. They also can have parts made from Teflon, polyester or polyethylene terephthalate.
Coronary artery bypass graft (CABG) procedures involve bypassing a weakened or damaged artery with another vessel to bypass the blocked and diseased portion of the coronary artery and maintain blood flow. The vessels most often used are the saphenous vein in the leg, the radial artery in the arm or the mammary artery from the chest wall. Vessel harvesting may be performed with an open incision or endoscopically. Endoscopy allows for a small, minimally invasive incision to be made rather than the much larger incision required for open harvesting. Endoscopic vessel harvesting (EVH) devices have become the standard of care for vessel harvesting during CABG procedures performed in the United States. The vessels obtained using EVH devices provide excellent conduit quality and hemostasis results. Furthermore, EVH procedures reduce patient discomfort and scarring as well as recovery time for the patient. This acts to improve patient outcomes and increase overall satisfaction.